A more mature phenotype of blood mononuclear phagocytes is induced by fluvastatin treatment in hypercholesterolemic patients with coronary heart disease

Citation
G. Rothe et al., A more mature phenotype of blood mononuclear phagocytes is induced by fluvastatin treatment in hypercholesterolemic patients with coronary heart disease, ATHEROSCLER, 144(1), 1999, pp. 251-261
Citations number
59
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
ATHEROSCLEROSIS
ISSN journal
00219150 → ACNP
Volume
144
Issue
1
Year of publication
1999
Pages
251 - 261
Database
ISI
SICI code
0021-9150(199905)144:1<251:AMMPOB>2.0.ZU;2-K
Abstract
Monocytes are recruited as the principal inflammatory cells into the athero sclerotic lesion. In a previous study we demonstrated that a low HDL-choles terol and the apo E4 allele are associated with an increased proportion of blood monocytes that are characterized by a high expression of Fc gamma-RII Ia (CD16), a dim expression of the lipopolysaccharide (LPS) receptor (CD14) and a high expression of beta(1)- and beta(2)-integrins (Rothe et al. Arte rioscler Thromb Vase Cell Biol 1996;16:1437-1447). In this study, 79 hyperc holesterolemic patients were treated either with the HMG CoA reductase inhi bitor fluvastatin in combination with diet or with placebo and diet in a do uble-blind and randomized multicenter study, and monitored for the potentia l effects on the phenotype of peripheral blood monocytes. At baseline, in t he whole group of hypercholesterolemic patients the population size of thes e more mature monocytes (CD14(dim)CD16(+)) was positively correlated to tri glyceride (P=0.003) and total serum cholesterol levels (P = 0.012) confirmi ng our previous study. Fluvastatin treatment for 52 weeks was associated wi th a 24.2% reduction in LDL-cholesterol (P < 0.001) as well as a 40.7% decr ease in the expression density of CD14 on all monocytes (P = 0.027). A 24.5 % decrease (P < 0.001) of the population of less differentiated CD14(bright )CD16(-) monocytes and an 83.1% increase (P = 0.029) of the population of m ore differentiated CD14(dim)CD16(+) monocytes further confirmed this modifi cation of the phenotype of peripheral blood monocytes. The positive pre-stu dy correlation of the CD14(dim)CD16(+) monocyte subset to the serum cholest erol concentration, but inverse changes of both parameters under fluvastati n therapy, in conclusion indicate that fluvastatin exerts an as yet unchara cterized immunomodulatory effect on either monocyte maturation and differen tiation, or extravasation which may also depend on the endothelial phenotyp e that is independent of the change in serum lipids. (C) 1999 Elsevier Scie nce Ireland Ltd. All rights reserved.